Literature DB >> 6760190

Interactions of metal-nucleotide complexes with aspartate carbamoyltransferase in the crystalline state.

R B Honzatko, W N Lipscomb.   

Abstract

We report the results of crystallographic difference maps at 3.0-A resolution of complexes of metal-nucleoside triphosphates with aspartate carbamoyltransferase (carbamoylphosphate:L-aspartate carbamoyltransferase, EC 2.1.3.2) from Escherichia coli. The complexes Gd3+-ATP, Al3+-ATP, and Gd3+-CTP bind to the allosteric effector domain of the enzyme in nearly the same orientation as the metal-free nucleotides. The result is consistent with kinetic observations of nearly identical allosteric efficacy of ATP and CTP and their complexes with cations. The effector Gd3+-GTP, however, binds in a distinctly different conformation and location than does 8-bromoguanosine 5'-triphosphate, reported in a separate investigation [Honzatko, R. B. & Lipscomb, W.N. (1982) J. Mol. Biol. 160, 265-286]. The difference in the binding modes of Gd3+-GTP and the bromo derivative suggests a possible mechanism for the relief of allosteric inhibition of GTP due to metal cations. We observe no binding of metal-nucleoside triphosphates in the region of the phosphate crevice of aspartate carbamoyltransferase, consistent with the reduced ability of metal nucleotides to compete with carbamoyl phosphate for the active site. However, a single Gd3+ ion binds in the region of the active site as evidenced by strong density. The binding of cations near the active site probably causes the inhibition of catalysis observed in kinetics experiments reported earlier [Honzatko, R.B., Lauritzen, A.M. & Lipscomb, W.N. (1981) Proc. Natl. Acad. Sci. USA 78, 898-902].

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6760190      PMCID: PMC347300          DOI: 10.1073/pnas.79.23.7171

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

1.  The enzymology of control by feedback inhibition.

Authors:  J C GERHART; A B PARDEE
Journal:  J Biol Chem       Date:  1962-03       Impact factor: 5.157

2.  Ultraviolet absorption spectra of adenosine-5'-triphosphate and related 5'-ribonucleotides.

Authors:  R M BOCK; N S LING; S A MORELL; S H LIPTON
Journal:  Arch Biochem Biophys       Date:  1956-06       Impact factor: 4.013

3.  The 5.5 Angstrom resolution structure of the regulatory enzyme, asparate transcarbamylase.

Authors:  D C Wiley; D R Evans; S G Warren; C H McMurray; B F Edwards; W A Franks; W N Lipscomb
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1972

4.  The purification of aspartate transcarbamylase of Escherichia coli and separation of its protein subunits.

Authors:  J C Gerhart; H Holoubek
Journal:  J Biol Chem       Date:  1967-06-25       Impact factor: 5.157

5.  Interactions of phosphate ligands with Escherichia coli aspartate carbamoyltransferase in the crystalline state.

Authors:  R B Honzatko; W N Lipscomb
Journal:  J Mol Biol       Date:  1982-09-15       Impact factor: 5.469

6.  Crystal and molecular structures of native and CTP-liganded aspartate carbamoyltransferase from Escherichia coli.

Authors:  R B Honzatko; J L Crawford; H L Monaco; J E Ladner; B F Ewards; D R Evans; S G Warren; D C Wiley; R C Ladner; W N Lipscomb
Journal:  J Mol Biol       Date:  1982-09-15       Impact factor: 5.469

7.  Ion-exchange thin-layer chromatography. 13. Resolution of complex nucleoside triphosphate mixtures.

Authors:  J Neuhard; E Randerath; K Randerath
Journal:  Anal Biochem       Date:  1965-11       Impact factor: 3.365

8.  Metal cation influence on activity and regulation of aspartate carbamoyltransferase.

Authors:  R B Honzatko; A M Lauritzen; W N Lipscomb
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

  8 in total
  1 in total

1.  The use of nucleotide analogs to evaluate the mechanism of the heterotropic response of Escherichia coli aspartate transcarbamoylase.

Authors:  J B Sakash; A Tsen; E R Kantrowitz
Journal:  Protein Sci       Date:  2000-01       Impact factor: 6.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.